J G Lainchbury
Overview
Explore the profile of J G Lainchbury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bridgman P, Lainchbury J, Hii T
Heart Lung Circ
. 2015 Sep;
24(12):1238.
PMID: 26361819
No abstract available.
2.
Saphenous vein graft aneurysm fistula formation causing right heart failure: an unusual presentation
Boon K, Arshad M, Singh H, Lainchbury J, Blake J
Intern Med J
. 2015 Sep;
45(11):1185-9.
PMID: 26361745
Saphenous vein graft aneurysm (SVG) formation after coronary artery bypass grafting is a rare complication of the surgery. We present a case of a 68-year-old man with an unusual presentation...
3.
MacKenzie K, Simcock J, Lainchbury J, Currie M, Lynn K
Transplant Proc
. 2009 Dec;
41(10):4414-5.
PMID: 20005411
Myocardial metastasis from a cutaneous squamous cell carcinoma (SCC) is rare. Herein we have presented a case of metastasis from cutaneous SCC to the myocardium in a renal transplant recipient,...
4.
Sharp C, Gardiner S, Jensen B, Roberts R, Troughton R, Lainchbury J, et al.
Pharmacogenomics J
. 2009 Apr;
9(3):175-84.
PMID: 19365402
The aims of this study were to examine the relationships between CYP2D6 genotype and metoprolol dose, S- and R-metoprolol concentrations and clinical effects in patients with systolic heart failure. Data...
5.
Hillock R, Frampton C, Yandle T, Troughton R, Lainchbury J, Richards A
Heart
. 2007 Jul;
94(5):617-22.
PMID: 17639095
Background: Natriuretic peptides have actions likely to ameliorate cardiac dysfunction. B-type natriuretic peptide (BNP) is indicated as treatment for decompensated cardiac failure. Objective: To determine the utility of BNP in...
6.
Nicholls M, Lainchbury J, Lewis L, McGregor D, Richards A, Troughton R, et al.
Peptides
. 2002 Jan;
22(11):1745-52.
PMID: 11754960
Although the biological effects of adrenomedullin (AM) and PAMP have been reported extensively in animal studies and from in-vitro experiments, relatively little information is available on responses to the hormone...
7.
Cataliotti A, Malatino L, Jougasaki M, Zoccali C, Castellino P, Giacone G, et al.
Mayo Clin Proc
. 2001 Nov;
76(11):1111-9.
PMID: 11702899
Objectives: To determine levels of natriuretic peptides (NPs) in patients with end-stage renal disease (ESRD) and to examine the relationship of these cardiovascular peptides to left ventricular hypertrophy (LVH) and...
8.
Nicholls M, Lainchbury J, Richards A, Troughton R, Yandle T
Ann Med
. 2001 Oct;
33(6):422-7.
PMID: 11585103
The drug treatment of heart failure, once simple, has become complex. Apart from a loop diuretic and digoxin, most patients should now be receiving an angiotensin-converting enzyme inhibitor (or angiotensin...
9.
Chen H, Lainchbury J, Matsuda Y, Harty G, Burnett Jr J
Hypertension
. 2001 Aug;
38(2):187-91.
PMID: 11509474
Mild heart failure is characterized by increases in atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in the absence of activation of the renin-angiotensin-aldosterone system (RAAS). Vasopeptidase (VP) inhibitors...
10.
Richards A, Lainchbury J, Nicholls M
Lancet
. 2001 Jun;
357(9269):1635-6.
PMID: 11425362
No abstract available.